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Abstract
Vitamin-K is a demanding multi-functional health product in the market and 
belongs to a class of isoprenoid molecules that comprises methylnaphthoquinone 
(MK) unit attached to an isoprene side chain. They are fat soluble and differ in the 
extent of side chain & obtained in the nature as vitamin K1 (phylloquinone), mena-
quinone/vitamin K2, and other lipoquinones. Owing to their owned polyprenyl side 
chain, they are hydrophobic/lipophilic in nature. Generally, the synthesis of vitamin 
K and its variants suffers with isomerization (for example 11 isomers were identified 
for cis/trans MK-7). Naturally, in bio-systems vitamin K produces through shikimic 
acid pathway and terpene biosynthetic pathway for the synthesis of menaquinone 
part & prenyl side chain parts respectively. Menadione or its auxiliaries are com-
monly being used as substrates to the synthesis of vitamin K variants through 
the involvement of condensation reactions, Friedel-Craft alkylation’s, Claisen 
rearrangement, Diels-Alder reactions and others. Importantly, organometallic 
reagents, such as Grignard, Gilman, organotelluride and other reagents could be the 
promising and consistent choice of substrate to the synthesis of various vitamin K’s. 
Vitamin K is well known for blood coagulation. As an antihaemorrhagic vitamin, 
it’s also being the current interest for the treatment of bone and vascular diseases. 
In addition, vitamin k is indispensable for the activation of vitamin K dependent 
(VKD) proteins and that are present almost in all tissues and responsible for hemo-
stasis, bone mineralization, arterial calcification, apoptosis, phagocytosis, growth 
control, chemotaxis, and signal transduction. This chapter summarizes various 
synthetic approaches of vitamin K & derivatives and their biological functions.
Keywords: Vitamin K, Menaquinones, Biosynthesis, Synthetic auxiliaries, 
Organometallic reagents, MenJ, Vascular diseases, diabetes
1. Introduction
Vitamin K is a family of natural products, comprises vitamin K1 (phylloqui-
none), vitamin K2 (methylnaphthoquinones/menaquinones-MK) and vitamin 
K3 (menadione). These are structurally methylated napthoquinones possess 
isoprene side chain (vitamin K1 & vitamin K2) and they vary in the extent of 
isoprene side chain, in terms of number of isoprene units and its level of satura-
tion [1–5]. However, these structural changes are apparently simple, but needs 
exist in its specific stereochemistry to exhibit their biological functions. These are 
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the fat-soluble compounds and pertains to a class of lipoquinones [6]. Vitamin K2 
are varied on the basis of number of isoprene units present in the side chain and 
they denoted as MK-n (n – number of isoprene units; Figure 1). The vitamin K2 if 
contains saturated isoprene units referred as MK-n(m-H2), wherein m is a roman 
numeral represents isoprene unit number in the side chain which underwent reduc-
tion. Among the two natural forms of vitamin K, vitamin K1 presents in green leafy 
vegetables, for example, kale, collard greens, turnip greens, iceberg lettuce, broc-
coli, spinach, and brussels sprouts. The Vitamin K2 presents naturally in eggs, meet, 
fermented foods (natto, cheese, yogurt and sauerkraut) also present in bacteria, 
for example, MK-9 is found in mycobacterium with nine isoprene units and also its 
reduced derivative at second isoprene unit MK-9(II-H2) could be active as electron 
transport agent in [3, 7]. In humans, these menaquinones display several biologi-
cal properties, including facilitating blood coagulation [8, 9]. In bacteria, these 
molecules assisting the synthesis of ATP through transport of electrons between 
the membrane-bound protein complexes and thus acting as electron acceptors and 
donors in the respiratory electron transport [10, 11]. Vitamin K and its analogues 
could not synthesize by mankind/animals. So, its required to supply an adequate 
amount through the dietary sources.
2. Vitamin K biosynthesis
Naturally, bacteria producing different variants of vitamin K. Among the 
aerobic bacteria, most of its Gram-negative bacteria contain ubiquinone as the sole 
quinone, whereas the menaquinone is the only quinone presents in aerobic Gram-
positive bacteria. But, in the case of anaerobic bacteria, irrespective of whether 
it is Gram-positive or Gram-negative, it produces benzoquinones (ubiquinone), 
naphthoquinones (menaquinones; MK-n), demethylmenaquinones (DMK-n) [12]. 
The Gram-negative bacteria, such as, Escherichia coli and Salmonella enterica serovar 
Typhimurium possesses these isoprenoid quinone molecules, viz., benzoquinones 
and naphthoquinone. In E. coli, it contains MK-8 and DMK-8 as the major naphtho-
quinones & in addition, it also comprises MK-6, MK-7, MK-9 and DMK-9 in minor 
quantities (Figure 2) [13].
These menaquinones have prenyl side chains with all-trans configurations. 
MK-10 and MK-11 are the isoforms of vitamin K2 and are produced from bacteroi-
des. MK-7 produced from veillonella sp. and MK-6 is from Eubacterium lentum. The 
menaquinone nucleus of vitamin k was being synthesized in the nature by shikimic 
acid pathway and that can be described as a “metabolic tree with many branches 
and was derived from isochorismate via chorismate. The prenyl side chains in the 
Figure 1. 
Structures of vitamin K.
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molecules are synthesized before its incorporation into the final compound through 
the terpene biosynthetic pathway and are derived from prenyl diphosphate, and the  
methyl groups in the vitamin K are derived from S-adenosylmethionine. The 
menaquinone biosynthesis involves the introduction of prenyl side chain, and 
that is accompanied by the loss of the carboxyl group and then occurred the 
C-methylation on quinone moiety [12].
Cox and Gibson discovered in 1964, shikimate was present in menaquinone of  
E. coli, and thus it could be the first report as an evidence to shikimate pathway to 
the synthesis of menaquinones. The chemical degradation reaction of labeled iso-
lated MK-8 displayed that all the radioactivity is associated with degraded product 
phthalic anhydride. It indicated that the benzene ring of naphthoquinone part in 
the vitamin K2 was procured from shikimate in the bacteria [14]. It was further 
established that, the menaquinone biosynthesis was started with shikimate as a 
starting precursor and it was confirmed from a complete degradation study of the 
menaquinone which was constructed by the labeled shikimate molecule. This study 
was indicated that all the seven carbon atoms of shikimate were incorporated in the 
naphthoquinone part of menaquinone [15], and the remaining 3 carbon atoms were 
revealed to be derived from the 2-ketoglutarate (Figure 3) [16, 17].
Shikimate pathway for the synthesis of menaquinones is presented in Figure 4. 
Shikimate was proposed to converted initially into chorismite before its incorpora-
tion into menaquinone [15]. In E. coli, isochorismate formation occurred from 
chorismite and it was mediated by isochorismate synthase (encoded as MenF). The 
source of the hydroxyl group in the isochorismate could be either molecular oxygen 
(occur in aerobic organism), or intramolecular -OH group transfer or from the 
solvent water [18]. Later, it was postulated that, the 2-ketoglutarate gives succinic 
semialdehyde anion of TPP through a TPP-dependent decarboxylation and that 
catalyzes by 2-ketoglutarate decarboxylase (KDC) [16, 19]. Subsequently, this anion 
reacts with isochorismate and produces 2-succinyl-6-hydroxy-2,4-cyclohexadiene-
1-carboxylate (SHCHC). MenD protein was found that it incorporated both SHCHC 
synthase & KDC activities and was encoded with a single gene [20]. Further studies 
Figure 2. 
Structures of vitamin K2 (MK-n) & DMK-n.
Figure 3. 
a) Sequential formations in the biosynthesis of menaquinones; b) the preliminary precursors in MK-n 
biosynthesis.
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shown that, SHCHC formation is proceeded through the formation of 2-succinyl-
5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate (SEPHCHC) and was 
catalyzed by SEPHCHC synthase [21]. As this SEPHCHC compound unstable, under 
mild basic conditions, it converts to SHCHC spontaneously [22]. This in vivo conver-
sion was carried out by SHCHC synthase encoded by menH gene (Ser-His-Asp; a 
catalytic triad) [23]. Later, the removal of water molecule from SHCHC to produces 
benzenoid compound, o-succinylbenzoate (OSB) and this transformation was 
carried out by OSB synthase & encoded as menC [24]. Bryant and Bentley described 
the transformation of OSB in to the 1,4-dihydroxy-2-naphthoate (DHNA) [25]. It 
was derived by ATP and CoA, so that OSB-CoA could be the proposed intermediate 
driven by the menE gene. Two enzymatic activities are worked on this conversion, 
viz., OSB-CoA synthetase and DHNA synthase. Due to the un-stability of OSB-
CoA, as an intermediate it was converted to DHNA through the involvement of 
DHNA-CoA [26]. Further Bentley was shown that the conversion of DHNA to DMK 
was happened in the extracts of E. coli [27]. The transformation of DHNA to DMK 
occurs through the exchange of carboxyl with isoprenpoid side chain. Both these 
processes, prenylation and decarboxylation perhaps occur at a single reactive center 
[28]. The MenA enzyme has carried out this process with octaprenyl PPi [29, 30]. 
Finally, the conversion of DMK to MK was happened by a methyltransferase, and 
that uses S-adenosylmethionine as the methyl donor [25, 31]. Moreover, Meganathan 
and group was extensively studied and reviewed detailed mechanistic studies for the 
shikimate pathway mechanism for the biosynthesis of vitamin K2 [12, 32].
3. Various synthetic approaches to vitamin K
In 1939, Fieser [33], Binkley [34], and Almquist [35] were reported initially 
the synthesis of vitamin K1 independently. The condensation reaction of either 
menadione/2-methyl-1,4-naphthohydroquinone with natural phytol in the presence 
of oxalic acid or zinc dust in acetic acid produce vitamin K1 (Figure 5).
Figure 4. 
Biosynthetic pathway of Menaquinone molecules.
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The initial synthetic approaches were generally proceeding through the usage 
of Friedel-Craft alkylation’s for introducing the side chains through its coupling to 
menadions, which led to the generation of mixture of isomers at the Δ2 position 
and produced E-isomer as the major (90%). Later it was developed by Lindlar to 
accomplish the complete retention of configuration of the side chain by taking the 
use of menadiol ester (menadiol 1-benzoate) in the catalytic amount of BF3.Et2O 
instead of menadione [36]. But the reaction suffers with the allylic alcohol instability 
to the acidic reaction conditions. Later days, the synthesis of vitamin K was achieved 
by coupling reactions of protected menaquinones with side chains, the protection 
is depending on the nature of the substrates and deprotection protocols. Transition 
metals (Ni [37], Ag [38]) show huge applicability in these coupling reactions to the 
synthesis of vitamin K. Furthermore, organometallics did this synthesis through 
the reactions of their metallonaphthalenes with corresponding side chain halides. 
Among, Grignard reagents were given excellent reactions with 99% stereo reten-
tion of the E-configuration. By using this magnesium organometallics Evans and 
Hoffman did a regiospecific isoprenylation of naphthoquinones to the vitamin K 
[39]. In this reaction, trimethylsilyl cyanide (TMSCN) added 2-methoxy-3-methyl-
1,4-naphthoquinone gave the protected quinone wherein cyanide was acted as a cata-
lyst. This protected quinone underwent reaction with prenyl magnesium bromide 
followed by a Cope rearrangement to obtained the protected MK-1. It’s deprotection 
was later performed with AgF, consequently it afforded the MK-1 (Figure 6).
In addition, Organocuprates were also being used to the synthesis of vitamins K’s. 
Menaquinone and phylloquinone are synthesized by Chenard group, from the reac-
tion of Gilman based bisketals of quinone substrate with allyl halides and it afforded 
high yields and good stereoselectivity at the Δ2 position of the vitamin K (Figure 7). 
The quinone bromide underwent metalation to produce the corresponding cuprate, 
and its reactivity was varied with different electrophilic substrates (RX). Among the 
tested electrophilic substrates, if the electrophilic group is small enough (allyl bro-
mide) then the two alkyl groups of cuprate reagent were being used being transferred 
in the reaction. If the reaction with bulkier electrophilic halide (for example benzyl 
chloride/bromide, cyclohexanecarbonyl acid chloride), cuprate can transform only 
one alkyl group [40]. Syper group synthesized protected forms of MK-1 and MK-2 
in appreciable yields through the coupling reaction of prenyl bromide and geranyl 
bromide with 2-bromo-3-methyl-1,4-dimethoxynaphthalene [41]. Generally, these 
organometallics (Grignard reagents, organocuprates and organolithiums) mediated 
synthesis of vitamin K required the usage of protected quinones to avoid the side 
reactions. Unprotected quinones could also give the vitamin k synthesis through their 
direct coupling with organostannates [42] and organisilanes [43].
Figure 5. 
The first synthesis of vitamin K1.
Figure 6. 
Grignard reagent mediated synthesis of MK-1.
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Figure 8. 
Methide annulation to a one-pot synthesis of vitamin K.
Tso and group developed an efficient and conceptually distinguished one-pot 
protocol to the synthesis of vitamin k, wherein the 3-substituted isobenzofuranone 
was treated with a base, the generated quinone methide which underwent an 
anionic [4 + 2] cycloaddition reaction with the alkenyl phenyl-sulfone (dienophile) 
and that was being synthesized from the corresponding allyl phenylsulfone and 
various prenyl bromide (RBr). Finally, the vitamin K was produced by the elimina-
tion of sulfone from the intermediate. This method was very compatible to the 
synthesis of phylloquinone and different menaquinone variants MK-1, MK-2 and 
MK-9 about 60–65% yields (Figure 8) [44].
In 2015, Mal et al., extended this protocol to the synthesis of menadione deriva-
tives (MK-n molecules) by a base mediated reaction of 3-substituted phthalide with 
methyl methacrylate [45]. The yield of the reaction was verified in this reaction 
with various leaving groups, such as - methoxy, phenyl sulfonyl, isonitrile, thiophe-
nyl, and nitrile. The nitrile leaving group in the substrate was found to be the best 
suitable one for the reaction. The 3-nitrilephthalide is to be a menadione auxiliary to 
the reaction of MK-n variants (Figure 9). The reaction was proceeds through a base 
mediated anionic driven annulation of 3-nucleofugal phthalides with α-alkyl/aryl 
acrylates followed by demethoxycarbonylation. If the polyprenyl acrylates are to be 
the substrates, then various analogs of menadione were being produced (MK-n).
Side chain functionalization methods were also being developed to the synthesis 
of vitamin K analogs. These derivatized vitamin K are received a great deal of interest 
to reveal the structure activity relationship studies (SAR). These analogs were also 
proved to be as inhibitors of vitamin K dependent carboxylase and vitamin K epoxide 
reductase [46]. The side chain stereochemistry is very essential to exhibit the biologi-
cal activity, as the E-isomers of these vitamins are producing activity and the isomers 
with Z-configuration could lead to loss of their activity. The longer chain in the mena-
quinones causes to account lower biological activities due to their hydrophobicity [47].
Snyder and group during their sustained efforts to retain the stereochemistry of 
α-isoprene double bond, they introduced the alkylation of enolates to the synthesis 
of vitamin K [38]. The synthesis involves the interaction of nucleophilic aromatic 
component to the receptive prenyl component through its enolized nucleophile. 
Figure 7. 
Menaquinone analogs synthesized by organocuprates.
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Initially, the menadiol forms its potassium salt in presence of either potassium 
hydride or potassium methoxide and then underwent prenylation through the eno-
late alkylation, later in presence of silver oxide get oxidized into prenyl fragment 
substituted menadione (MK-2 and MK-9) and was shown in Figure 10.
However, these enolyte alkylations were successful but not very practical. 
To accomplish the practical methods, Snyder group developed transmetallation 
method for the synthesis of vitamin K [ 38]. Lithium, magnesium and copper had 
used to convert 2-bromomenadiol to its corresponding metallo derivative. As an 
electrophilic partner authors chosen initially aldehydes, but aldehydes are unsuc-
cessful as the resultant alcohol functionality removal afforded either vinyl alkenes 
or α-isoprene double bond isomerization. Later, the prenyl halides are found to be 
the appropriate substrates of electrophiles for these transformations. Primarily, 
reactions were performed to evaluate the stereoretention of the α-isoprene double 
bond in each of the 2-metallo derivatives. As per their expectation, all these metallo 
derivatives could not affect the configuration of the isoprene component of the 
vitamins. It was found that, organo magnesium reagents are more efficient than 
organocuprates and that in turn efficient than organo lithium reagents. Among 
the prenyl halides, prenyl bromides are generated excellent yields of menaquinone 
analogs (Figure 11). The coupling of 2-magnesio or 2-cupro-3-methyl-l,4-dime-
thoxynaphthalene with geranyl bromide produced in >90% yield. In this method, 
MK-9 was obtained in 73% yield by treating solanesyl bromide with menadiol.
In the various synthetic strategies to the vitamin K in the literature, Friedel-
Crafts alkylation protocol of menadiols is the most popular across the literature. 
Hirschmann group developed a method wherein the applicability of various Lewis 
and Bronsted-Lowry acids were being used for the synthesis of vitamin K1 [48]. 
Monoacetate of menadiol substrate was treated with phytol in presence of various 
acids. Among, the acids, BF3.Et2O afforded appreciable yields (67%) rather others 
being tested KHSO4, oxalic acid and Duolite C-60. After Friedel-Crafts alkylation, 
finally, the acetate group was removed by the treatment with Ag2O (Figure 12).
Figure 9. 
Anionic annulation of 3-nucleofugal phthalides to the synthesis of vitamin K.
Figure 10. 
Enolate alkylation of menadiols to MK-n synthesis.
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Figure 12. 
Application of Friedel-crafts alkylation to the synthesis of vitamin K1.
Figure 13. 
BF3.Et2O catalyzed Claisen rearrangement to vitamin K1.
Later, in 1990 Schmid and group enriched the yield of the reaction by treating 
the reaction of menadiol monoacetate with phytyl chloride in presence of a base 
potassium carbonate, wherein O-phytylated derivative had obtained. This was 
further undergoing Claisen rearrangement under acidic treatment with catalytic 
amount of BF3.Et2O to C-phytylated product in 76–80% yield and the ratio of the 
configurations of E and Z isomers was found to be 97:3. The deacetylation was 
carried out in basic medium (Figure 13). Vitamin K1 obtained in this procedure is to 
be 96.5% and with E-configuration, Z -configuration compound was with very low 
yield (3%) [49].
Apart from the electrophilic side chain attachment to the menadiones, radicals 
also found to do the same work to make the synthesis of vitamin K. Jacobson and 
coworkers in 1972, developed a method to the alkylation of quinones by the use of 
radicals and that were produced by metal/persulphate catalyzed decorboxylation 
of the corresponding carboxylic acid. 4-Methyl-3-pentenoic acid produced the 
3,3-dimethylallyl radical while in presence of AgNO3, (NH4)2S2O8. Initially Ag
+ is 
reacted with S2O8
−2 to form Ag+2 and which abstract an electron from carboxylic 
Figure 11. 
Efficient transmetallation reaction to menaquinones.
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acid to produce allyl radical by the ejection of CO2. This allyl radical resonates and 
unexpectedly less stable isoform γ,γ-dimethylallylquinone was given the product 
instead to α,α-dimethylallylquinone (Figure 14). By this procedure MK-1 obtained 
in 70% yield as a γ,γ-dimethylallylquinone as to hold a stable alkene [50].
Later, Yamago et al., found the applicability of organotellurium compounds to 
the radical coupling reactions with a variety of quinone substrates [51]. This method 
could offer the general protocol to the synthesis of polyprenyl menadiones with com-
plete retention of stereochemistry. Organotellurides were prepared by SmI2 mediated 
coupling reaction of its corresponding bromides with ditollyl ditelluride (Tol)2Te2. 
This telluride later produced prenyl radical under photo/thermal energy source and 
that interact with menadione to produce respective MK-n related to the length of 
the prenyl side chain. While geranyl tolyl telluride (73:23 mixture of the trans and 
cis isomers) react with 2-methyl-1,4-naphthoquinone to produce MK-2 in moderate 
yield. The stereochemistry of the product (7:3) informed that the reaction gave the 
retention of stereo chemistry of organic telluride in to the product (Figure 15).
Diels-Alder reactions were useful to construct napthoquinine structural unit, 
as Rüttimann and group being used this concept to develop protocol for the 
synthesis of vitamin K1. The reaction of dihydroisobenzofurane was performed 
with activated alkyne dienophile (96:4 E/Z) at 80°C overnight to form the tri-
methyl sillyl ether of Diels-Alder adduct and its reaction further carried out with 
methanol and then methyl group at C2 position is achieved through the reduction 
of ester with bis(2-methoxyethoxy)aluminum hydride followed by air oxidation 
produces vitamin K in moderate yield (Figure 16a, 50%) [52]. During the reac-
tion the isoprene double bond configuration was not altered. Later, he developed 
the reaction by taking an auxiliary to support the reaction. Rüttimann along 
with Büchi had taken cyclopentadiene as a substrate auxiliary and its reaction 
was carried out with menadione to generate Diels-Alder adduct (Figure 16b). 
Prenylation/ alkylation at C3 position of Diels-Alder adduct was performed under 
strong base (KOtBu, NaNH2, KNH2).
Figure 14. 
Ag+/S2O8
−2 mediated radical directed synthesis to MK-1.
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Figure 16. 
a) Diels-Alder reaction mediated synthesis to vitamin K1; b) Cyclopentadiene auxiliary driven synthesis to 
vitamin K1.
Inspired by menadione auxiliary applicability in the synthesis of vitamin K1, 
Battula, S., and group, thought to introduce the polyprenyl side chain on to the 
menadione to synthesis MK-n variants. This menadione surrogate was utilized 
to the synthesis of MK-9 in one pot protocol. The reaction of 1-Chloro-N,N,2-
trimethyl-1-propenylamine (Ghosez reagent) with solanesol and Diels-Alder adduct 
of menadione was produced MK-9, wherein solanesol chlorination was happened 
initially to produce solanesyl chloride and that was treated with menadione auxil-
iary in presence of a strong base KOtBu. Finally, the reaction was treated with acetic 
acid followed by tributylmethylammonium bromide to eliminate the by-products. 
In this procedure, MK-9 was obtained in 77% yield (Figure 17). The reaction with 
bromine based Ghosez reagent was generated MK-9 with 65% yield, as its higher 
leaving group ability than chloride facilitates to the formation of side reactions like 
Sn
2’ reaction and cyclic reactions [53].
In the view of the requirement of MK-7 owing to its high lipophilicity and good 
bioavailability in small intestines and about 3 days half-life than compare to other 
menaquinones and ubiquinone, Aneta et al. in 2016 developed a practical synthetic 
strategy for vitamin K2 (MK-7) [54]. The synthesis of MK-7 was achieved in all the 
trans forms in the side chain through 1 + 6 convergent synthetic protocol and that 
involves condensation of menadione monoprenyl fragment with all-trans hexaprenyl 
Figure 15. 
Organo telluride mediated radical coupling synthesis to vitamin K.
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bromide fragment. All-trans hexaprenyl bromide fragment was being synthesized 
from two tryprenyl molecule, i.e., trans,trans-farnesol. This method also imple-
mented to the industrial level synthesis of MK-7 to compensate the need of dietary 
supplement as it affords high purity of the final compound MK-7 (Figure 18).
Among the two coupling components, hexaprenyl fragment was obtained 
from commercially available trans,trans farnesol & trans,trans farnesyl bromide 
by the following synthetic steps. The other substrate monoprenyl 1,4-dimethoxy 
naphthalene was produced from menadione and phenylsulfonyl, hydroxy isoprene 
compounds. Both these substrates were coupled in the presence of strong base 
Figure 17. 
One-pot synthesis to MK-9.
Figure 18. 
Convergent synthesis of MK-7.
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Figure 19. 
Convergent synthesis of MK-6.
t-BuOK, followed by the desulfonation at the side chain was performed by LiEt3BH 
in presence of Pd(dppe)Cl2. Later, the 1,4-dimethoxy naphthalene was oxidized 
with CAN. This “1 + 6” convergent synthetic strategy is based on the condensation 
of monoprenyl derivative of menadione with hexaprenyl molecule was produced 
MK-7 in all trans stereo isoforms of side chain.
As this method was convenient in the availability of starting substrates and 
perfect stereochemistry of the product, Battula, S., and group developed the similar 
convergent synthetic strategy to MK-6 as well (vitamin K2 variant) in all the trans 
forms of side chain through “1+5 convergent synthetic approach” of pentaprenyl 
chloride with monoprenyl menadione derivative [53]. During this survey, authors 
found that bromo based polyprenyl substrate was produced Sn
2’ side reaction prod-
uct along with the main product. In addition, during LiEt3BH mediated desulfona-
tion, it evolves a by-product Et3B and that leads to give cyclized side product. These 
limitations in the synthetic strategy interrupt the purification processes and effect 
the yield of the final product MK-6. To minimize these limitations, the reaction 
strategy was incorporated less efficient leaving group/ more efficient nucleophile 
(Cl) in the polyprenyl derivative to eliminate all Sn
2’ side reactions and thus enhance 
the yield and purity of the product. Further in the reaction sequence, to prevent 
the side reactions due to the Et3B by product (from the desulfonation reaction), the 
corresponding desulfonation reaction was treated with acetic acid to quench the 
by-product Et3B. Authors were applied the same strategy to the one-pot synthetic 
protocol to MK-9 (vitamin K2 variant). The reaction of phenyl sulfone derivative 
of monoprenyl menadiol with pentaprenyl chloride was occurred in presence of 
base (produced by a sequential reaction from the combination of geraniol and 
farnesol), and it was followed by the desulfonation reaction of the resulting product 
with LiEt3BH in presence of Pd(dppe)Cl2. Finally, the product in the desulfonation 
process was subjected for the oxidation with CAN reagent and it produced the final 
product MK-6 (Figure 19).
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Lipshutz and group developed a method to introduce a one carbon handle at 
the C-3 position of menadione molecules and it offered a good synthetic protocol 
to a wide range of MK-derivatives through a highly probable SN
2 substitutions and 
organometallic cross-coupling reactions [55]. The protocol was initiated by the 
reaction of menadione molecule with formaldehyde and HCl gas, resulting to pro-
duce 3-chloromethyl menadione in appreciable yield. The synthesis of vitamin K1 
was achieved through the reaction of 3-chloromethyl menadione with phytylalane 
in presence of NiCl2, Ph3P and n-BuLi. Whereas MK-3 was prepared in the reaction 
with farnesylalane with E-configuration at the coupling position (α-isoprene double 
bond). The required stereoselective organoalanes [56] were being synthesized by 
Negishi cross coupling reaction (Figure 20).
In the early of 1900s, Saa and group successfully established a protocol by 
which aldehydes were being used as electrophiles to launch the prenyl side chains 
in to menadione molecules in the production of MK-2 and MK-4 [57]. During this 
protocol, bismethyl ether of 2-bromomenadiol undergoes reaction with n-BuLi, 
and generates organolithium reagent through the lithium-bromide ion exchange 
process. This organolithium reagent attacks on commercially available prenyl alde-
hydes (citral & geranylgeranial) under BIHY reaction conditions (Birch hydrolysis) 
produces corresponding benzyl alcohols respectively [58]. The formed alcohol was 
protected with TMSCl in the presence of HMDS/HMDSZ (hexamethyldisilazane 
reagent). This protected form of alcohol converted to free methylene group when 
it reduced in presence of Li & liquid ammonia [59]. The resulting stereochemistry 
of the α-isoprene double bonds were with more than 95% E alkene as presents in 
Figure 20. 
Synthesis of MK-3 & vitamin K1 through using phytyl and prenyl organoalane compounds.
Figure 21. 
Synthesis of MK-2 & MK-4 by using birch hydrolysis conditions.
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the precursor aldehyde. The methyl ethers of menadione nucleus were removed by 
CAN to generate MK-2 and MK-4 (Figure 21).
4. Brief discussion of vitamin K biology
Biologically these molecules are very important and have been reported for sev-
eral biomedical purposes. Owing to their severe liphophilicity/ hydrophobicity due 
to containing multiple isoprene units in the side chain, they are with less solubility 
and thus causes to difficulties to assess in-vitro studies as these are performed in 
aqueous solutions. These napthoquinones have been displayed promising biological 
activities against tubercular [60, 61], cancer [62–64], cardiovascular [65, 66] and 
diabetes [67, 68].
In mycobacteria, MenJ (Rv0561c) is a highly conserved reductase enzyme 
demonstrated in mycobacteria knock out strains, and that reduces isoprene units 
in menaquinones through electron transport, thereby the menaquinones found 
in mycobacteria are in reduced form (Figure 22) [3, 69, 70]. But the ATP levels 
depends on the total menaquinones present in membrane of bacteria and that facili-
tated by disruption of MenJ functioning of menaquinone reduction. However, these 
partially saturated menaquinone’s role is unclear in various organisms, but they are 
found to essential for the growth and survival of pathogenic . The mycobacterial 
electron transport system is increased by hydrogenation of MK-9, so the survival 
of the bacteria inside J774A.1 macrophage like cells significantly declined by the 
deletion of MenJ and that found to be not required for bacterial growth in culture. 
Thereby, MenJ perhaps identified as a conditional drug target for Mycobacterium 
tuberculosis while in the context of infected macrophage [69].
As a known fact that vitamin K is an essential nutrient that displays potential 
anticancer properties on a variety of tumor cells [71, 72]. Quinones are the impor-
tant natural and synthetic molecules as they have considerable biological potential. 
These compounds are display antitumor activity through several mechanism of 
action. Generally, these molecules have problems with respect to solubility, stabil-
ity and toxicity. Owing to this reason, these molecules are using as drugs through 
alternative procedures like controlled-release system of these quinones, and it could 
be a strategy for improving the pharmacological profile of this class of compounds. 
Vitamin K mediated mechanisms proceeds to prevent the cell proliferation and 
growth although unclear, but mostly through oxidative effect and direct arylation 
of thiols may deplete glutathione and cell cycle arrest. The quinone structure in 
vitamin k is responsible for the modulation of redox-balance and induction of 
oxidative stress in cancer cells. The anticancer properties of vitamin K1 and vitamin 
K2 mostly mediated by non-oxidative mechanisms, probably through transcription 
Figure 22. 
MenJ reductase reduction transformation of MK-9.
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factors, but vitamin K3 does by reducing oxidative stress and arylation at higher 
concentrations. It’s been evidenced that, bulk doses of vitamin K2 (2.5 grams given 
per day) could be safe and not caused to enhancing toxicity levels [73]. Vitamin K2 
also prevents hepatocarcinogenesis in patients with hepatic cirrhosis [74]. Quinones 
generally undergo one-electron and two-electron reductions, leads to produce 
semiquinone radicals, as well as hydroquinone’s respectively. These factors reduce 
oxidative stress through the consumption of superoxide radicals and cause to cancer 
cell homeostasis.
Vitamin K known to reduce complications and improve clinical issues of pre-dia-
betes and diabetes. Type-2 diabetes mellitus (T2DM) demonstrates when pancreatic 
β-cells fail to compensate for enduring elevated blood glucose (hyperglycemia) 
that occurs when glucose uptake in the insulin-sensitive tissues become imbalanced 
during insulin resistance [75]. Recent clinical trials display T2DM risk reduction was 
happened with vitamin K supplementation, in addition vitamin K2 improvs insulin 
sensitivity through the involvement of vitamin K-dependent-protein osteocalcin 
metabolism and that favors β-cell proliferation, insulin secretion and sensitivity. 
Vitamin K2 shows better effect than vitamin K1 in the context of T2DM [76].
Vitamin K2 also useful to the bone and cardiovascular related problems. As we 
know, lower intake of calcium can decrease the bone mineral density, and thus 
can increase the risk of bone fractures. Although supplemental calcium helps 
to enhance bone mineral density and strength (prevent osteoporosis), recent 
evidences informed that higher consumption of calcium supplements may lead to 
the risk for heart diseases and also can cause to accelerated deposit of calcium in 
blood-vessel walls and soft tissues. While the vitamin K2 is related with the inhibi-
tion of arterial calcification and arterial stiffening, which means that increased 
vitamin K2 intake could be lower the risk of vascular damage as it activates matrix 
GLA protein (MGP), and that inhibits the deposits of calcium on the walls, and 
thus reducing the health risks that are associated with calcium levels [77, 78]. The 
essential component to the synthesis of Gla-protein family is vitamin K and that 
is very important to the hemostasis as its deficiency causes to acute and dangerous 
condition due to excessive bleeding.
5. Conclusion
This chapter summarized various synthetic approaches of different variants of 
vitamin K and their biological application. Although several methods are available, 
but menadione and its substrate auxiliaries (for example, Diels-Alder adducts, 
organometallic compounds and others) are the choices to the synthesis of vitamin 
K’s. Their synthesis proceeds through several reactions like, Friedel-Craft alkyla-
tion’s, condensation reactions, Claisen rearrangement, Diels-Alder reactions and 
others and by the involvement of nucleophilic and free radical reactions. It also 
included the information regarding their natural sources. As the huge importance 
of vitamin K to the mankind, it is being used as food supplementation because it’s 
not produced by mankind. The major dietary source of vitamin K is phylloquinone, 
which is synthesized by plants and algae. Vitamin K2 (various forms of menaqui-
none; MK-4 to MK14), produces from bacteria in the human gut and plays a lesser 
role in the provision of vitamin K, since it is taken up by the body to only a limited 
extent. In infants the development of vitamin K is very low, due to its deficiency 
they are offering vitamin K immediately after the birth and the initial days life. Also 
incorporated the utility of vitamin K, as its great role in the blood coagulation, in 
the maintenance of bone health and healthy nervous system, prevention of cardio 
vascular disease and diabetes.
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Menadione, a synthetic product and being used as a pharmaceutical interested 
molecule. Menaquinone-4 mainly resides in the brain tissues and generates from 
a tissue-specific transformation of vitamin K. The metabolism of vitamin K is 
an essential factor to study further vitamin K biology. Further knowledge in this 
context of vitamin K proved to be beneficial in many areas of science for example 
like medicine [79].
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